Press release
Clinical And Preclinical Combination Study: Competitor Analysis Of Inhibitory and Stimulatory Immunomodulators in Immuno-Oncology
Market Research Report
Competitor Analysis: Inhibitory and Stimulatory Immunomodulators in Immuno-Oncology
This product consists of four reports in pdf format describing the competitive field of new molecular entities directed against inibitory as well stimulatory immune checkpoints on T-cells, antigen presenting cells (APCs)/dendritic cells or tumor cells and against immunosuppressive factors in the tumor microencironment, including Treg cells, tumor-associated macrophages (TAM), myeloid derived suppressor cells (MDSC).
Purchase of this product includes a 6-month online access to the data of the reports and any updates since the publication date as well as the clinical and preclinical combination studies. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
Each of the four reports can be obtained individually, but the package of the four reports provides a 40% discount on the regular prices:
Competitor Analysis: PD-1 and PD-L1 Immune Checkpoint Inhibitors 2016
Competitor Analysis: Inhibitors of Negative Immune Checkpoints CTLA-4, LAG-3, TIM-3 & Others
Competitor Analysis: Activators of Immune Checkpoints CD40, GITR, OX40, 4-1BB, CD27 & ICOS
Competitor Analysis: Tumor Microenvironment Modulation via IDO, TGF-B/R, CXCR4, CSF-1R, CD47-SIRPa, Adenosine, STING & Others
Targets of Immunomodulators are inhibitory as well as stimulatory immune checkpoints and from the tumor microenvironment:
Negative Immune Checkpoints:
PD-1(programmed cell death 1
PD-L1(programmed cell death ligand 1 (PD-L1)
(Cytotoxic T-Lymphocyte-Associated Protein-4; CD152)
(Lymphocyte Activation Gene 3; CD223)
(T-cell Immunoglobulin domain and Mucin domain 3; HAVCR2)
(V-region Ig-containing Suppressor of T-cell Activation) Receptor
(Carcino-Embryonic Antigen Cell Adhesion Molecule 1)
BTLA (B- and T-Lymphocyte Attenuator)
GARP (Glycoprotein A Repetitions Predominant)
TIGIT(T-cell Immunoreceptor with Ig and ITIM domains)
IL-10(Interleukin-10)
B7-H3(CD273)
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=895857
Stimulatory Immune Checkpoints:
CD40 (TNFSFR5)
GITR(Glucocorticoid-Induced Tumor Necrosis Factor Receptor; TNFSFR18)
OX40(CD134; TNFSFR4)
4-1BB(CD137; TNFSFR9)
CD27 (TNFSFR7)
ICOS(Inducible Co-Stimulator)
Immunosuppressive tumor microenvironment:
IDO (Indoleamine 2,3-dioxygenase
TDO ( Tryptophan 2,3 dioxygenase)
TGF-B/R ( Transforming Growth Factor beta/Receptor)
CXCR4 (Chemokine Receptor Type 4)
CSF-1R ( Colony Stimulating Factor-1 Receptor)
CD47 SIRPa (Signal Regulatory Protein Alpha)
Adenosine Pathway: Adenosine 2A Receptor (A2AR), CD73, CD39 & adenosine
STING (STimulator of INterferon Genes) Receptor
Others ( e.g. arginase)
More than 90 unique molecules (mostly antibodies) targeting inhibitory and stimulatory immunomodulators are in clinical development as monotherapy or in combination with other checkpoint modulators or targeted cancer therapeutics. At least further 31 molecules are undergoing IND-enabling studies.
The reports include compilations of currently active projects in research and development of immunomodulators in immuno-oncology. In addition, each report lists company-specific R&D pipelines of cancer immunomodulators. Competitor projects are listed in a tabular format providing information on:
Drug Codes,
Target / Mechanism of Action,
Class of Compound,
Company,
Product Category,
Indication,
R&D Stage and
additional comments with a hyperlink leading to the source of information.
About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=895857
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Clinical And Preclinical Combination Study: Competitor Analysis Of Inhibitory and Stimulatory Immunomodulators in Immuno-Oncology here
News-ID: 540499 • Views: …
More Releases from Immuno-Oncology
PharmaPoint : Immuno-Oncology Strategic Insight - Multi-Indication And Market Si …
Albany, New York, July 19, 2017 : Recent research and the current scenario as well as future market potential of " Immuno-Oncology Strategic Insight- Market Size : Overview, Research, Share and Trends 2017 " globally.
GlobalData estimates that the total IO market will be worth approximately $14 billion in 2019, rising to $34 billion by 2024 in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). The main drivers of…
More Releases for Competitor
Agrochemicals Market 2030 Competitor Analysis
The Agrochemicals Market is expected to register a CAGR of 4% from 2024 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
Access PDF: https://www.theinsightpartners.com/sample/TIPRE00003559/?utm_source=OpenPR&utm_medium=10864
Product type: Fertilizers, Pesticides & Plant growth regulators.
Crop Type: Cereals and Grains; Fruits and Vegetables; Oilseeds and Pulses.
Application Method: Foliar Spray, Soil Treatment & Seed Treatment.
A few players operating in the global agrochemicals market include…
Plant Growth Regulators Market Growth & Competitor Segment Analysis, With Busine …
Plant Growth Regulators Market is expected to rise from its initial estimated value of USD 5.32 billion in 2018 to an estimated value of USD 9.15 billion by 2026 registering a CAGR of 7.0% in the forecast period of 2019-2026. This rise in the market can be attributed to the growing awareness towards the green technology and high demand of the organic foods.
FREE | Sample Copy Of Report@ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-plant-growth-regulators-market
Key…
2018 Banking Competitor Profile: Barclays
Barclays is one of the largest banks in the UK, and is a leading provider of all the main banking products. Mortgages are a particular strength for the bank - it has won a number of awards for its product range and has an NPS score three times higher than the market average. Barclays customers are heavy users of mobile banking - a quarter use this channel on a daily…
Banking Competitor Profile: Santander
Santander is a leading UK provider, and has achieved notable success in recent years with its 123 Current Account, which has attracted substantial numbers of new customers. It also recently acquired a specialist provider of motor finance, which has boosted its market share in lending. Although Santander’s costs relative to income are in line with those of other banks, price competition has hit its net interest margins, and consequently its…
Banking Competitor Profile: Santander
Santander is a leading UK provider, and has achieved notable success in recent years with its 123 Current Account, which has attracted substantial numbers of new customers. It also recently acquired a specialist provider of motor finance, which has boosted its market share in lending. Although Santander’s costs relative to income are in line with those of other banks, price competition has hit its net interest margins, and consequently its…
Insurance Competitor Profile: Aviva 2016
MarketResearchReports.Biz presents this most up-to-date research on "Insurance Competitor Profile: Aviva 2016"
Description
This profile offers a review of Aviva, its business structure and strategy, its financial performance, and a SWOT analysis.
Aviva has 34 million customers worldwide and 16 million in the UK (before the deduction of Friends Life Groups overlapping customers). Aviva has a presence in 16 countries. Outside of the UK, it has a strong presence in Canada, France, Ireland,…
